Can serum granulocyte-macrophage colony-stimulating factor and CCL17 levels be a marker of disease activation in spondyloarthritis?

Rezan Koçak Ulucaköy, Ayza Kılıç, Sevilay Batıbay, İdil Melis Çobanoğlu, Elif Nur Yıldırım Öztürk, Zafer Günendi, Aylin Sepici Dinçel, Feride Nur Göğüş

DOI: 10.46497/ArchRheumatol.2024.10360

Issue: Volume 39 - Issue 3 - September 2024
92 113

Prevalence and characteristics of juvenile fibromyalgia syndrome in pediatric rheumatic diseases: A comparative study

Gülcan Özomay Baykal, Duygu Kurtuluş, Serap Ata, Betül Sözeri

DOI: 10.46497/ArchRheumatol.2024.10562

Issue: Volume 39 - Issue 3 - September 2024
115 114

Osteoporosis knowledge and awareness among rheumatoid arthritis patients: A cross-sectional controlled study

Öykü Tomay Aksoy, Öznur Kutluk, İlhan Sezer

DOI: 10.46497/ArchRheumatol.2024.10171

Issue: Volume 39 - Issue 3 - September 2024
109 132

Is the development of arrhythmia predictable in rheumatoid arthritis?

Arif Gülkesen, Emine Yıldırım Uslu, Gürkan Akgöl, Gökhan Alkan, Mehmet Ali Kobat, Mehmet Ali Gelen, Muhammed Fuad Uslu

DOI: 10.46497/ArchRheumatol.2024.10590

Issue: Volume 39 - Issue 3 - September 2024
108 141

Validity and reliability of the Turkish version of Exercise Benefits/ Barriers Scale: Perceived exercise benefits and barriers of patients with different axial spondyloarthritis subtypes

Devrim Can Sarac, Elif Durak Ediboglu, Derya Ozer Kaya, Gozde Duran, Emre Alp Akatay, Sercan Gucenmez, Servet Akar, Deniz Bayraktar

DOI: 10.46497/ArchRheumatol.2024.10720

Issue: Volume 39 - Issue 3 - September 2024
125 169

The impact of ex vivo ozone injection into the synovial fluid in patients with knee osteoarthritis: A controlled clinical trial

Emre Ata, Semiha Özgüç, Mustafa Hüseyin Temel, Hakan Beyaztaş, Selman Aktaş, Eray Metin Güler

DOI: 10.46497/ArchRheumatol.2024.10375

Issue: Volume 39 - Issue 3 - September 2024
113 167